Ronald T. Wester

1.1k citations

20 papers · 806 indexed · h-index 15

Co-authors: Frederick E. Ziegler Roger B. Ruggeri John A. Williams Patricia G. Cosgrove M J Bamberger Ronald W. Clark Thomas Sand Tamara A. Sutfin
Topics: Chemical Synthesis and Analysis (5 papers)Asymmetric Synthesis and Catalysis (4 papers)Renin-Angiotensin System Studies (3 papers)
Cited by: Endocrinology, Diabetes and Metabolism Organic Chemistry Cancer Research
Journals: Journal of the American Chemical Society Journal of Medicinal Chemistry Arteriosclerosis Thrombosis and Vascular Biology
Partner nations: United States United Kingdom

In The Last Decade

Ronald T. Wester

20 papers receiving 774 citations

Peers

Countries citing papers authored by Ronald T. Wester

Since Specialization

Citations

This map shows the geographic impact of Ronald T. Wester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald T. Wester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald T. Wester more than expected).

Fields of papers citing papers by Ronald T. Wester

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald T. Wester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald T. Wester. The network helps show where Ronald T. Wester may publish in the future.

Co-authorship network of co-authors of Ronald T. Wester

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald T. Wester. A scholar is included among the top collaborators of Ronald T. Wester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald T. Wester. Ronald T. Wester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Potent and selective TYK2-JH1 inhibitors highly efficacious in rodent model of psoriasis 2022 ·Bioorganic & Medicinal Chemistry Letters ·Silvana Leit,Jeremy R. Greenwood,Sayan Mondal,(unknown),Markus K. Dahlgren,Geraldine Harriman,Joshua J. Kennedy‐Smith,Rosana Kapeller,(unknown),Donna L. Romero,Angela V. Toms,Mee Shelley,Ronald T. Wester,William Westlin,Joshua McElwee,Wenyan Miao,Scott D. Edmondson,C. E. Masse	10
2	Accelerating drug discovery through tight integration of expert molecular design and predictive scoring 2016 ·Current Opinion in Structural Biology ·Robert Abel,Sayan Mondal,C. E. Masse,Jeremy R. Greenwood,Geraldine Harriman,Mark A. Ashwell,Sathesh Bhat,Ronald T. Wester,Leah L. Frye,Rosana Kapeller,Richard A. Friesner	47
3	Synthesis of the CETP Inhibitor Torcetrapib: The Resolution Route and Origin of Stereoselectivity in the Iminium Ion Cyclization 2006 ·Organic Process Research & Development ·David B. Damon,Robert W. Dugger,(unknown),Roger B. Ruggeri,Ronald T. Wester,Meihua Tu,Yuriy A. Abramov	36
4	Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein 2004 ·Arteriosclerosis Thrombosis and Vascular Biology ·Ronald W. Clark,Tamara A. Sutfin,Roger B. Ruggeri,(unknown),Eliot Sugarman,(unknown),Patricia G. Cosgrove,Thomas Sand,Ronald T. Wester,John A. Williams,Michael E. Perlman,M J Bamberger	283
5	Zoniporide: a potent and highly selective inhibitor of human Na+/H+ exchanger-1 2002 ·European Journal of Pharmacology ·Ravi B. Marala,Janice A. Brown,Jimmy Kong,W. Ross Tracey,Delvin R. Knight,Ronald T. Wester,Dexue Sun,Scott P. Kennedy,E.S. Hamanaka,Roger B. Ruggeri,Roger J. Hill	38
6	Discovery of zoniporide: A potent and selective sodium–hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility 2001 ·Bioorganic & Medicinal Chemistry Letters ·Angel Guzmán-Pérez,Ronald T. Wester,Mary C. Allen,Janice A. Brown,(unknown),Ewell R. Cook,Wesley Day,E.S. Hamanaka,Scott P. Kennedy,Delvin R. Knight,Paul Kowalczyk,Ravi B. Marala,Christian J. Mularski,(unknown),Roger B. Ruggeri,W. Ross Tracey,Roger J. Hill	75
7	A Novel Sodium-Hydrogen Exchanger Isoform-1 Inhibitor, Zoniporide, Reduces Ischemic Myocardial Injury in Vitro and in Vivo 2001 ·Journal of Pharmacology and Experimental Therapeutics ·Delvin R. Knight,Andrew H. Smith,D. M. Flynn,(unknown),(unknown),Jimmy Kong,Ravi B. Marala,Ronald T. Wester,Angel Guzmán-Pérez,Roger J. Hill,William P. Magee,W. Ross Tracey	66
8	7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as Novel Inhibitors of Human Eosinophil Phosphodiesterase 1998 ·Journal of Medicinal Chemistry ·Allen J. Duplantier,Catharine J. Andresen,John B. Cheng,Victoria L. Cohan,Christian Decker,Frank M. DiCapua,Kenneth G. Kraus,(unknown),Claudia R. Turner,John P. Umland,J. W. Watson,Ronald T. Wester,Alison S. Williams,John A. Williams	22
9	Cloning, Expression and Pharmacological Characterization of Rabbit Adenosine A1 and A3 Receptors 1997 ·Journal of Pharmacology and Experimental Therapeutics ·Roger J. Hill,Joseph J. Oleynek,Christopher F. Hoth,(unknown),Weifan Weng,Ronald T. Wester,W. Ross Tracey,Delvin R. Knight,Richard Buchholz,Scott P. Kennedy	31
10	Discovery of Inhibitors of Human Renin with High Oral Bioavailability 1995 ·Advances in experimental medicine and biology ·Dennis J. Hoover,Bruce A. Lefker,Robert L. Rosati,Ronald T. Wester,Edward F. Kleinman,Jasjit S. Bindra,William F. Holt,William R. Murphy,Michael L. Mangiapane,(unknown),Ian Williams,(unknown),(unknown),Richard M. Shepard,Mark Gardner,Mark R. Nocerini	11
11	Terlakiren: An orally active renin inhibitor in the guinea pig 1995 ·Drug Development Research ·Michael L. Mangiapane,Ronald T. Wester,William F. Holt,(unknown),(unknown),(unknown),Andrew H. Smith,(unknown),William R. Murphy	2
12	Preparation of a novel series of phosphonate norstatine renin inhibitors 1994 ·Bioorganic & Medicinal Chemistry Letters ·Ronald T. Wester,Robert Chambers,Michael D. Green,William R. Murphy	32
13	Dihydropyridines: a new class of angiotensin II antagonists 1994 ·Bioorganic & Medicinal Chemistry Letters ·Ronald T. Wester,Christian J. Mularski,(unknown),Paul Da Silva Jardine,(unknown),(unknown),(unknown),Albert Rauch,Karen W. Hoover,Christine Kennedy,Michael Burkard,Michael L. Mangiapane,Charles E. Aldinger,Kelvin Cooper,Philip A. Carpino	3
14	3-Methyl-.gamma.-butyrolactones as templates for the synthesis of polypropionates: the basic strategy 1988 ·Journal of the American Chemical Society ·Frederick E. Ziegler,(unknown),John K. Thottathil,Ronald T. Wester	27
15	Applications of the 3-methyl-.gamma.-butyrolactone strategy to the synthesis of polypropionates: the Prelog-Djerassi lactonic ester, ent-invictolide, and the C19-C27 fragment of rifamycin S 1988 ·Journal of the American Chemical Society ·Frederick E. Ziegler,(unknown),(unknown),(unknown),Ronald T. Wester	40
16	Regiochemical control in the hemiacetalization of a dihydroxydialdehyde. An application of the use of homochiral 3-methyl-δ-butyrolactones to the construction of homochiral tripropionate units. 1986 ·Tetrahedron Letters ·Frederick E. Ziegler,Ronald T. Wester	22
17	On the extent of racemization of allylic esters during palladium—mediated alkylation with homochiral 3-methyl-δ-butyrolactone derivatives 1986 ·Tetrahedron Letters ·Frederick E. Ziegler,(unknown),Ronald T. Wester	18
18	R-3-methyl-γ-butyrolactone as a template for the synthesis of (+)-invictolide 1986 ·Tetrahedron Letters ·Frederick E. Ziegler,(unknown),Ronald T. Wester	16
19	Acyclic stereocontrol via the claisen rearrangement: a formal synthesis of (+) tirandamycic acid 1984 ·Tetrahedron Letters ·Frederick E. Ziegler,Ronald T. Wester	23
20	On the mechanism of the addition of dithianylidene anions to cyclic α,β-unsaturated ketones 1982 ·Tetrahedron Letters ·Frédéric Ziegler,(unknown),Ronald T. Wester	4

About Ronald T. Wester

Ronald T. Wester is a scholar working on Organic Chemistry, Physiology and Cardiology and Cardiovascular Medicine, having authored 20 papers that have together received 806 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (5 papers), Asymmetric Synthesis and Catalysis (4 papers) and Renin-Angiotensin System Studies (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (190 citations), Organic Chemistry (274 citations) and Cancer Research (85 citations). Ronald T. Wester has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Frederick E. Ziegler, Roger B. Ruggeri, John A. Williams, Patricia G. Cosgrove, M J Bamberger, Ronald W. Clark, Thomas Sand, Tamara A. Sutfin, Michael E. Perlman and Eliot Sugarman. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact